Immediate Impact

1 from Science/Nature 63 standout
Sub-graph 1 of 19

Citing Papers

Upadacitinib Induction and Maintenance Therapy for Crohn’s Disease
2023 Standout
Ulcerative Colitis in Adults
2023 Standout
4 intermediate papers

Works of James Proulx being referenced

Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: a phase 3 randomised non-inferiority trial
2015
Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: results from two randomized, placebo-controlled, phase III trials
2015
and 2 more

Author Peers

Author Last Decade Papers Cites
James Proulx 538 288 51 270 4 805
M. Buonanno 470 276 48 225 7 732
Stephen Calabro 718 279 77 126 11 959
Scott Fretzin 793 454 63 293 14 980
A. David Burden 651 283 180 105 9 919
Jocelyne Papacharalambous 364 580 35 300 7 896
Chandrasena Pamulapati 553 212 48 281 8 694
Yichuan Xia 618 330 63 151 5 854
Alan Silverman 351 146 134 74 10 850
J Sloan-Lancaster 724 63 145 165 9 958
Nicholas V.C. Chia 649 285 85 112 8 770

All Works

Loading papers...

Rankless by CCL
2026